Commercialization of cell therapies – biopreservation’s make or break impact: an interview with Mike Rice
Top 10 most read items on RegMedNet in 2016
Scaling human pluripotent stem cell expansion and differentiation: are cell factories becoming a reality?
Qualification of academic facilities for small-scale automated manufacture of autologous cell-based products
The translation of cell-based therapies: clinical landscape and manufacturing challenges
Comparability: manufacturing, characterization and controls, report of a UK Regenerative Medicine Platform Pluripotent Stem Cell Platform Workshop, Trinity Hall, Cambridge, 14–15 September 2015
Regulatory requirements in the good manufacturing practice production of an epithelial cell graft for ocular surface reconstruction